» Articles » PMID: 2898912

Vasoactive Intestinal Peptide in the Lung

Overview
Specialty Science
Date 1988 Jan 1
PMID 2898912
Citations 6
Authors
Affiliations
Soon will be listed here.
Citing Articles

Aviptadil: A multifaceted approach to mitigating hypoxemia in acute respiratory distress syndrome.

Mehta Y, Mehta C, Chandrasekaran A Respir Med Case Rep. 2024; 48:101992.

PMID: 38370871 PMC: 10869253. DOI: 10.1016/j.rmcr.2024.101992.


Brief Report: Rapid Clinical Recovery From Critical Coronavirus Disease 2019 With Respiratory Failure in a Pregnant Patient Treated With IV Vasoactive Intestinal Peptide.

Youssef J, Bitar M, Zahiruddin F, Al-Saadi M, Elshawwaf M, Yau S Crit Care Explor. 2022; 4(1):e0607.

PMID: 35018346 PMC: 8735760. DOI: 10.1097/CCE.0000000000000607.


Characterization of the rat vasoactive intestinal polypeptide receptor gene 5' region.

Pei L, Melmed S Biochem J. 1995; 308 ( Pt 3):719-23.

PMID: 8948424 PMC: 1136784. DOI: 10.1042/bj3080719.


Effects of vasoactive intestinal polypeptide on antigen-induced bronchoconstriction and thromboxane release in guinea-pig lung.

Ciabattoni G, Montuschi P, Curro D, Togna G, Preziosi P Br J Pharmacol. 1993; 109(1):243-50.

PMID: 8495242 PMC: 2175596. DOI: 10.1111/j.1476-5381.1993.tb13560.x.


Effects of epithelium removal on relaxation of airway smooth muscle induced by vasoactive intestinal peptide and electrical field stimulation.

FARMER S, Togo J Br J Pharmacol. 1990; 100(1):73-8.

PMID: 2196967 PMC: 1917444. DOI: 10.1111/j.1476-5381.1990.tb12054.x.